Kp Tissue Stock Today
| KPT Stock | CAD 10.21 0.01 0.1% |
PerformanceSolid
| Odds Of DistressTiny
|
KP Tissue is selling at 10.21 as of the 6th of January 2026; that is 0.1 percent decrease since the beginning of the trading day. The stock's open price was 10.22. KP Tissue has under 5 % chance of experiencing financial distress over the next 2 years and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 7th of December 2025 and ending today, the 6th of January 2026. Click here to learn more.
Business Domain Household & Personal Products | Category Consumer Defensive | Classification Consumer Staples |
KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in North America. KP Tissue Inc. was founded in 2012 and is headquartered in Mississauga, Canada. KP TISSUE operates under Household Personal Products classification in Canada and is traded on Toronto Stock Exchange.. The company has 10.01 M outstanding shares of which 345.08 K shares are now shorted by private and institutional investors with about 20.31 days to cover all short positions. More on KP Tissue
Moving together with KPT Stock
Moving against KPT Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
KPT Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. KP Tissue's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding KP Tissue or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
KP Tissue (KPT) is traded on Toronto Exchange in Canada and employs 12 people. KP Tissue is listed under Personal Care Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 102.28 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate KP Tissue's market, we take the total number of its shares issued and multiply it by KP Tissue's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. KP Tissue operates under Personal Care Products sector and is part of Consumer Staples industry. The entity has 10.01 M outstanding shares of which 345.08 K shares are now shorted by private and institutional investors with about 20.31 days to cover all short positions.
KP Tissue may have liquidity issues
Check KP Tissue Probability Of Bankruptcy
Ownership AllocationThe market capitalization of KP Tissue is C$102.28 Million. Around 98.84 % of KP Tissue outstanding shares are held by general public with 0.47 percent owned by insiders and only 0.69 (percent) by institutions. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check KPT Ownership Details
KP Tissue Historical Income Statement
KPT Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in KP Tissue without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
KP Tissue Corporate Management
Elected by the shareholders, the KP Tissue's board of directors comprises two types of representatives: KP Tissue inside directors who are chosen from within the company, and outside directors, selected externally and held independent of KPT. The board's role is to monitor KP Tissue's management team and ensure that shareholders' interests are well served. KP Tissue's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, KP Tissue's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Franois Paroyan | SVP Secretary | Profile | |
| Marc Fitzgerald | Corporate LP | Profile | |
| Susan Irving | Chief KPLP | Profile | |
| Michael Keays | Chief Officer | Profile | |
| Nancy Marcus | Chief LP | Profile | |
| Robert Martin | Senior Operations | Profile |
Other Information on Investing in KPT Stock
KP Tissue financial ratios help investors to determine whether KPT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KPT with respect to the benefits of owning KP Tissue security.